CY2361B1 - Anti-atherosclerotic agents. - Google Patents

Anti-atherosclerotic agents.

Info

Publication number
CY2361B1
CY2361B1 CY0300043A CY0300043A CY2361B1 CY 2361 B1 CY2361 B1 CY 2361B1 CY 0300043 A CY0300043 A CY 0300043A CY 0300043 A CY0300043 A CY 0300043A CY 2361 B1 CY2361 B1 CY 2361B1
Authority
CY
Cyprus
Prior art keywords
ester
dihydroequilin
alpha
sulfate
absence
Prior art date
Application number
CY0300043A
Other languages
English (en)
Inventor
Steven Jay Adelman
Kurt Edric Steiner
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/157,661 external-priority patent/US5482935A/en
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CY2361B1 publication Critical patent/CY2361B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
CY0300043A 1993-01-05 2003-05-15 Anti-atherosclerotic agents. CY2361B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77793A 1993-01-05 1993-01-05
US08/157,661 US5482935A (en) 1993-01-05 1993-12-01 Anti-atherosclerotic use of 17 alpha-dihydroequilin

Publications (1)

Publication Number Publication Date
CY2361B1 true CY2361B1 (en) 2004-06-04

Family

ID=26668138

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0300043A CY2361B1 (en) 1993-01-05 2003-05-15 Anti-atherosclerotic agents.

Country Status (17)

Country Link
EP (1) EP0678027B1 (es)
JP (1) JP3344585B2 (es)
CN (1) CN1071573C (es)
AT (1) ATE209495T1 (es)
AU (1) AU6015794A (es)
CA (1) CA2152187A1 (es)
CY (1) CY2361B1 (es)
DE (1) DE69331237T2 (es)
DK (1) DK0678027T3 (es)
ES (1) ES2165382T3 (es)
HK (1) HK1011282A1 (es)
IL (1) IL108155A (es)
MX (1) MX9400254A (es)
PH (1) PH30474A (es)
PT (1) PT678027E (es)
SG (1) SG52359A1 (es)
WO (1) WO1994015612A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855703B1 (en) * 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507889A (en) * 1968-06-11 1970-04-21 American Home Prod Process for the preparation of 17alpha-dihydroequilenin and related compounds
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
US4379780A (en) * 1980-09-29 1983-04-12 American Home Products Corporation 17 α-Dihydroequilin hapten and assay method

Also Published As

Publication number Publication date
DE69331237D1 (de) 2002-01-10
HK1011282A1 (en) 1999-07-09
MX9400254A (es) 1994-08-31
ES2165382T3 (es) 2002-03-16
IL108155A (en) 1999-08-17
EP0678027B1 (en) 2001-11-28
EP0678027A1 (en) 1995-10-25
ATE209495T1 (de) 2001-12-15
PH30474A (en) 1997-05-28
DK0678027T3 (da) 2002-03-18
CN1071573C (zh) 2001-09-26
WO1994015612A1 (en) 1994-07-21
AU6015794A (en) 1994-08-15
SG52359A1 (en) 1998-09-28
JP3344585B2 (ja) 2002-11-11
IL108155A0 (en) 1994-04-12
CN1096443A (zh) 1994-12-21
DE69331237T2 (de) 2002-06-13
PT678027E (pt) 2002-04-29
CA2152187A1 (en) 1994-07-21
JPH08505392A (ja) 1996-06-11

Similar Documents

Publication Publication Date Title
CA2213339A1 (en) Method of treating adenosine depletion
MY110734A (en) Improvements in or relating to dioic acids.
TW325996B (en) Anti-atherosclerotic composition containing 17α-dihydroequilin
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
HU9402914D0 (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
IL111293A0 (en) Pharmaceutical compositions comprising 5 alpha-reductase type 2 inhibitor for treating androgenic alopecia
GR3037031T3 (en) Dermatological preparation and method for treating actinic keratoses
MY121623A (en) Methods of preventing breast cancer.
HU9503578D0 (en) Androstane steroids as neurochemical initilators of change in human hypothalamic function and related pharmaceutical compositions and methods
AU573262B2 (en) Covalently bound heparin-antithrombin iii complex
AU4650596A (en) Composition and methods for transdermal delivery of acid-labile drugs
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
SG52359A1 (en) Anti-atherosclerotic agents
EP0715517A4 (en) ESTRENSTEROIDS AS NEUROCHEMICAL INITIATORS OF A CHANGE IN HUMOTHALM FUNCTION IN PEOPLE AND RELATED PHARMACEUTICAL PREPARATIONS AND METHODS
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
AU5278799A (en) Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof andpharmaceutical preparations containing said compounds
UA41376C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
MY104932A (en) Immunomodulatory azaspiranes
UA19610A (uk) Спосіб лікуваhhя опісторхозhої іhвазії
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
TW360538B (en) Pharmaceutical composition containing 4'-iodo-4'-deoxydoxorubicin for treatment of amyloidosis
HU9902219D0 (en) Process for the treatment of retching and sexual dysfunction by use of benz [cd]indole-6-carboxamides
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.